The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone ...

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible ...

Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...

The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...